The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer

被引:0
|
作者
Xiaofeng Gong
Danyu Du
Yanran Deng
Yuqi Zhou
Li Sun
Shengtao Yuan
机构
[1] China Pharmaceutical University,Jiangsu Key Laboratory of Drug Screening
[2] China Pharmaceutical University,Jiangsu Center for Pharmacodynamics Research and Evaluation
来源
Investigational New Drugs | 2020年 / 38卷
关键词
Ubiquitination; HUWE1; Cancer therapeutics; Drug discovery;
D O I
暂无
中图分类号
学科分类号
摘要
E3 ligases are a class of critical enzymes that can catalyse the transfer of ubiquitin (Ub) from an E2 enzyme to the substrate and are essential to cellular processes. The E3 ligase HUWE1 (also known as ARF-BP1, HECTH9, HSPC272, Ib772, LASU1, MULE, URE-B1, UREB1, and HECT, UBA and WWE domain-containing E3 ubiquitin protein ligase 1) is encoded by the huwe1 gene. HUWE1 is a key regulator of the DNA damage response, transcription, autophagy, apoptosis and metabolism in a variety of cancers. Due to its pivotal role in conferring substrate specificity, HUWE1 has attracted enormous attention as a promising anticancer drug target. In this review, we indicate the specific molecular structure of HUWE1 and its role in various cellular signalling pathways and highlight new insights into HUWE1 in cancer. Finally, we discuss outstanding questions regarding HUWE1 in oncology and highlight its limitations in drug development and clinical guidance to better define the role of HUWE1 in multiple cancers.
引用
收藏
页码:515 / 524
页数:9
相关论文
共 50 条
  • [31] Mitochondrial E3 ubiquitin ligase 1: A key enzyme in regulation of mitochondrial dynamics and functions
    Peng, Jun
    Ren, Kai-Di
    Yang, Jie
    Luo, Xiu-Ju
    MITOCHONDRION, 2016, 28 : 49 - 53
  • [32] Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation
    Zhou, Yuzheng
    Zheng, Rong
    Liu, Sixu
    Disoma, Cyrollah
    Du, Ashuai
    Li, Shiqin
    Chen, Zongpeng
    Dong, Zijun
    Zhang, Yongxing
    Li, Sijia
    Liu, Pinjia
    Razzaq, Aroona
    Chen, Xuan
    Liao, Yujie
    Tao, Siyi
    Liu, Yuxin
    Xu, Lunan
    Zhang, Qianjun
    Peng, Jian
    Deng, Xu
    Li, Shanni
    Jiang, Taijiao
    Xia, Zanxian
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (02)
  • [33] The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions
    Cai, Weijia
    Yang, Haifeng
    CELL DIVISION, 2016, 11
  • [34] The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions
    Weijia Cai
    Haifeng Yang
    Cell Division, 11
  • [35] Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models
    Viktoria Kunz
    Kathryn S. Bommert
    Jessica Kruk
    Daniel Schwinning
    Manik Chatterjee
    Thorsten Stühmer
    Ralf Bargou
    Kurt Bommert
    Scientific Reports, 10
  • [36] CHIP functions an E3 ubiquitin ligase of Runx1
    Shang, Yu
    Zhao, Xinghui
    Xu, Xialian
    Xin, Hong
    Li, Xueni
    Zhai, Yonggong
    He, Dacheng
    Jia, Baoqing
    Chen, Wei
    Chang, Zhijie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (01) : 242 - 246
  • [37] Chaperone functions of the E3 ubiquitin ligase CHIP
    Rosser, Meredith F. N.
    Washburn, Erin
    Muchowski, Paul J.
    Patterson, Cam
    Cyr, Douglas M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (31) : 22267 - 22277
  • [38] Roles of the HUWE1 ubiquitin ligase in nervous system development, function and disease
    Andrew C. Giles
    Brock Grill
    Neural Development, 15
  • [39] The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion
    Yuting He
    Jianming Zhou
    Qinsi Wan
    Investigational New Drugs, 2021, 39 : 713 - 723
  • [40] The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion
    He, Yuting
    Zhou, Jianming
    Wan, Qinsi
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 713 - 723